STOCK TITAN

Xeris Biopharma Holdings Stock Price, News & Analysis

XERS Nasdaq

Welcome to our dedicated page for Xeris Biopharma Holdings news (Ticker: XERS), a resource for investors and traders seeking the latest updates and insights on Xeris Biopharma Holdings stock.

Xeris Biopharma Holdings Inc (XERS) is a biopharmaceutical innovator developing ready-to-use therapies for complex conditions in endocrinology, neurology, and gastroenterology. This page aggregates official company announcements, regulatory milestones, and research developments for stakeholders tracking its progress.

Access timely updates on XERS' FDA-approved products including Gvoke (severe hypoglycemia), Recorlev (Cushing's Syndrome), and proprietary formulation platforms like XeriSol and XeriJect. Our curated news feed covers clinical trial results, partnership announcements, manufacturing updates, and financial disclosures essential for understanding the company's trajectory in advanced biotherapeutics.

This resource serves investors and healthcare professionals needing verified information about XERS' patient-centric solutions. Content is organized chronologically with clear sourcing to facilitate efficient research. Bookmark this page for structured access to earnings reports, regulatory filings, and scientific advancements from one of biopharma's most innovative formulation specialists.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.48%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.48%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.51%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.18%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.86%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.95%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.24%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.59%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.25%
Tags

FAQ

What is the current stock price of Xeris Biopharma Holdings (XERS)?

The current stock price of Xeris Biopharma Holdings (XERS) is $4.75 as of July 3, 2025.

What is the market cap of Xeris Biopharma Holdings (XERS)?

The market cap of Xeris Biopharma Holdings (XERS) is approximately 759.1M.
Xeris Biopharma Holdings

Nasdaq:XERS

XERS Rankings

XERS Stock Data

759.13M
153.34M
3.99%
42.87%
6.91%
Biotechnology
Pharmaceutical Preparations
Link
United States
CHICAGO